Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: A meta‐analysis

C Baiano, P Barone, L Trojano… - Movement …, 2020 - Wiley Online Library
Mild cognitive impairment associated with Parkinson's disease (PD) is a risk factor for the
development of dementia. Despite the importance of early identification of mild cognitive …

Marine algae-derived bioactive compounds: a new wave of nanodrugs?

F Menaa, U Wijesinghe, G Thiripuranathar… - Marine drugs, 2021 - mdpi.com
Marine algae are rich in bioactive nutraceuticals (eg, carbohydrates, proteins, minerals, fatty
acids, antioxidants, and pigments). Biotic (eg, plants, microorganisms) and abiotic factors …

Dynamic functional connectivity changes associated with dementia in Parkinson's disease

E Fiorenzato, AP Strafella, J Kim, R Schifano, L Weis… - Brain, 2019 - academic.oup.com
Dynamic functional connectivity captures temporal variations of functional connectivity
during MRI acquisition and it may be a suitable method to detect cognitive changes in …

Parkinson's disease dementia: a neural networks perspective

J Gratwicke, M Jahanshahi, T Foltynie - Brain, 2015 - academic.oup.com
In the long-term, with progression of the illness, Parkinson's disease dementia affects up to
90% of patients with Parkinson's disease. With increasing life expectancy in western …

Effects of physical exercise programs on cognitive function in Parkinson's disease patients: a systematic review of randomized controlled trials of the last 10 years

FC Da Silva, RR Iop, LC de Oliveira, AM Boll… - PloS one, 2018 - journals.plos.org
Background Given the relative importance of cognitive impairment, there was considerable
interest in identifying the cognitive profile of PD patients, in order to ensure specific and …

Cognitive impairment in Parkinson's disease: epidemiology, clinical profile, protective and risk factors

P Gonzalez-Latapi, E Bayram, I Litvan, C Marras - Behavioral Sciences, 2021 - mdpi.com
Cognitive impairment is a common non-motor symptom in Parkinson's Disease (PD) and an
important source of patient disability and caregiver burden. The timing, profile and rate of …

Diagnosis and management of Parkinson's disease

A Tarakad, J Jankovic - Seminars in neurology, 2017 - thieme-connect.com
Despite numerous efforts to identify specific and sensitive biomarkers, the diagnosis of
Parkinson's disease (PD) is still based on clinical criteria that include the presence of a …

Cognitive decline in Parkinson's disease: the complex picture

R Biundo, L Weis, A Antonini - npj Parkinson's Disease, 2016 - nature.com
Mild cognitive impairment (PD-MCI) and dementia (PDD) are among the most frequent non-
motor symptoms in Parkinson's disease (PD). PD-MCI is six times more likely than age …

Syntax, action verbs, action semantics, and object semantics in Parkinson's disease: Dissociability, progression, and executive influences

Y Bocanegra, AM García, D Pineda, O Buriticá… - Cortex, 2015 - Elsevier
Several studies have recently shown that basal ganglia (BG) deterioration leads to
distinctive impairments in the domains of syntax, action verbs, and action semantics. In …

Bioactive compounds from macroalgae in the new millennium: implications for neurodegenerative diseases

M Barbosa, P Valentão, PB Andrade - Marine drugs, 2014 - mdpi.com
Marine environment has proven to be a rich source of structurally diverse and complex
compounds exhibiting numerous interesting biological effects. Macroalgae are currently …